Candace S. Johnson - Publications

Affiliations: 
Biochemistry State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Biochemistry, Endocrinology Biology

96 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Bunch BL, Ma Y, Attwood K, Amable L, Luo W, Morrison C, Guru KA, Woloszynska-Read A, Hershberger PA, Trump DL, Johnson CS. Vitamin D enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk. Cancer Medicine. PMID 30972950 DOI: 10.1002/cam4.2119  0.44
2019 Wei L, Hussein AA, Ma Y, Azabdaftari G, Ahmed Y, Wong LP, Hu Q, Luo W, Cranwell VN, Bunch BL, Kozlowski JD, Singh PK, Glenn ST, Smith G, Johnson CS, et al. Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy. The Journal of Urology. PMID 30730413 DOI: 10.1097/JU.0000000000000142  0.44
2017 Ma Y, Luo W, Bunch BL, Pratt RN, Trump DL, Johnson CS. 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p. Oncotarget. 8: 60080-60093. PMID 28947955 DOI: 10.18632/oncotarget.19629  0.44
2017 Ma Y, Luo W, Bunch BL, Pratt RN, Trump DL, Johnson CS. 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p. Oncotarget. PMID 28778065 DOI: 10.18632/oncotarget.19629  0.44
2016 Wei L, Papanicolau-Sengos A, Liu S, Wang J, Conroy JM, Glenn ST, Brese E, Hu Q, Miles KM, Burgher B, Qin M, Head K, Omilian AR, Bshara W, Krolewski J, ... ... Johnson CS, et al. Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing. Bmc Medical Genomics. 9: 64. PMID 27756300 DOI: 10.1186/s12920-016-0226-1  0.44
2016 Luo W, Johnson CS, Trump DL. Vitamin D Signaling Modulators in Cancer Therapy. Vitamins and Hormones. 100: 433-72. PMID 26827962 DOI: 10.1016/bs.vh.2015.11.004  0.44
2016 Ma Y, Johnson CS, Trump DL. Mechanistic Insights of Vitamin D Anticancer Effects. Vitamins and Hormones. 100: 395-431. PMID 26827961 DOI: 10.1016/bs.vh.2015.11.003  0.44
2015 Wei L, Liu S, Conroy J, Wang J, Papanicolau-Sengos A, Glenn ST, Murakami M, Liu L, Hu Q, Conroy J, Miles KM, Nowak DE, Liu B, Qin M, Bshara W, ... ... Johnson CS, et al. Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib. Cold Spring Harbor Molecular Case Studies. 1: a000380. PMID 27148567 DOI: 10.1101/mcs.a000380  0.44
2015 Yao S, Haddad SA, Hu Q, Liu S, Lunetta KL, Ruiz-Narvaez EA, Hong CC, Zhu Q, Sucheston-Campbell L, David Cheng TY, Bensen JT, Johnson CS, Trump DL, Haiman CA, Olshan AF, et al. Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER Consortium. International Journal of Cancer. Journal International Du Cancer. PMID 26650177 DOI: 10.1002/ijc.29954  0.4
2015 Mazzilli SA, Hershberger PA, Reid ME, Bogner PN, Atwood K, Trump DL, Johnson CS. Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model. Cancer Prevention Research (Philadelphia, Pa.). PMID 26276745 DOI: 10.1158/1940-6207.CAPR-14-0403  0.4
2015 Wei L, Liu LT, Conroy JR, Hu Q, Conroy JM, Morrison CD, Johnson CS, Wang J, Liu S. MAC: identifying and correcting annotation for multi-nucleotide variations. Bmc Genomics. 16: 569. PMID 26231518 DOI: 10.1186/s12864-015-1779-7  0.4
2015 Bothwell KD, Shaurova T, Merzianu M, Suresh A, Kuriakose MA, Johnson CS, Hershberger PA, Seshadri M. Impact of Short-term 1,25-dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer. Cancer Prevention Research (Philadelphia, Pa.). PMID 26100522 DOI: 10.1158/1940-6207.CAPR-14-0454  0.4
2015 Steck SE, Arab L, Zhang H, Bensen JT, Fontham ET, Johnson CS, Mohler JL, Smith GJ, Su JL, Trump DL, Woloszynska-Read A. Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP. Plos One. 10: e0125151. PMID 25919866 DOI: 10.1371/journal.pone.0125151  0.4
2015 Qin M, Liu B, Conroy JM, Morrison CD, Hu Q, Cheng Y, Murakami M, Odunsi AO, Johnson CS, Wei L, Liu S, Wang J. SCNVSim: somatic copy number variation and structure variation simulator. Bmc Bioinformatics. 16: 66. PMID 25886838 DOI: 10.1186/s12859-015-0502-7  0.4
2015 Liu B, Conroy JM, Morrison CD, Odunsi AO, Qin M, Wei L, Trump DL, Johnson CS, Liu S, Wang J. Structural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectives. Oncotarget. 6: 5477-89. PMID 25849937  0.44
2015 Ma Y, Hu Q, Luo W, Pratt RN, Glenn ST, Liu S, Trump DL, Johnson CS. 1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 148: 166-71. PMID 25263658 DOI: 10.1016/j.jsbmb.2014.09.020  0.4
2014 Shen J, Hu Q, Schrauder M, Yan L, Wang D, Medico L, Guo Y, Yao S, Zhu Q, Liu B, Qin M, Beckmann MW, Fasching PA, Strick R, Johnson CS, et al. Circulating miR-148b and miR-133a as biomarkers for breast cancer detection. Oncotarget. 5: 5284-94. PMID 25051376  0.4
2014 Ma Y, Trump DL, Johnson CS. Vitamin D and miRNAs in cancer. Current Gene Therapy. 14: 269-75. PMID 25039615  0.4
2014 Ajibade AA, Kirk JS, Karasik E, Gillard B, Moser MT, Johnson CS, Trump DL, Foster BA. Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer. Plos One. 9: e89555. PMID 24586868 DOI: 10.1371/journal.pone.0089555  0.4
2014 Singh PK, Preus L, Hu Q, Yan L, Long MD, Morrison CD, Nesline M, Johnson CS, Koochekpour S, Kohli M, Liu S, Trump DL, Sucheston-Campbell LE, Campbell MJ. Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients. Oncotarget. 5: 824-40. PMID 24583788  0.4
2014 Yao S, Hong CC, McCann SE, Zirpoli G, Quan L, Gong Z, Johnson CS, Trump DL, Ambrosone CB. Combined effects of circulating levels of 25-hydroxyvitamin d and Th1 and th2 cytokines on breast cancer estrogen receptor status. Cancers. 6: 211-25. PMID 24473087 DOI: 10.3390/cancers6010211  0.4
2014 Morrison CD, Liu P, Woloszynska-Read A, Zhang J, Luo W, Qin M, Bshara W, Conroy JM, Sabatini L, Vedell P, Xiong D, Liu S, Wang J, Shen H, Li Y, ... ... Johnson CS, et al. Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America. 111: E672-81. PMID 24469795 DOI: 10.1073/pnas.1313580111  0.4
2014 Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SN, Block AW, Adjei AA, Barcos M, Griffiths EA, Thompson JE, Wang ES, ... Johnson CS, et al. Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Cancer. 120: 521-9. PMID 24166051 DOI: 10.1002/cncr.28368  0.4
2013 Liu B, Morrison CD, Johnson CS, Trump DL, Qin M, Conroy JC, Wang J, Liu S. Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges. Oncotarget. 4: 1868-81. PMID 24240121  0.4
2013 Luo W, Hu Q, Wang D, Deeb KK, Ma Y, Morrison CD, Liu S, Johnson CS, Trump DL. Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue. Oncotarget. 4: 1472-83. PMID 23978847  0.4
2013 Godoy AS, Chung I, Montecinos VP, Buttyan R, Johnson CS, Smith GJ. Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate. American Journal of Physiology. Endocrinology and Metabolism. 304: E1131-9. PMID 23548616 DOI: 10.1152/ajpendo.00602.2012  0.4
2013 Muindi JR, Adjei AA, Wu ZR, Olson I, Huang H, Groman A, Tian L, Singh PK, Sucheston LE, Johnson CS, Trump DL, Fakih MG. Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes. Hormones & Cancer. 4: 242-50. PMID 23456391 DOI: 10.1007/s12672-013-0139-9  0.4
2013 Ma Y, Yu WD, Hidalgo AA, Luo W, Delansorne R, Johnson CS, Trump DL. Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system. Cell Cycle (Georgetown, Tex.). 12: 743-52. PMID 23388458 DOI: 10.4161/cc.23846  0.4
2013 Luo W, Yu WD, Ma Y, Chernov M, Trump DL, Johnson CS. Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells. Cancer Research. 73: 2289-97. PMID 23358686 DOI: 10.1158/0008-5472.CAN-12-4119  0.44
2013 Luo W, Hershberger PA, Trump DL, Johnson CS. 24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics. The Journal of Steroid Biochemistry and Molecular Biology. 136: 252-7. PMID 23059474 DOI: 10.1016/j.jsbmb.2012.09.031  0.44
2013 Ma Y, Yu WD, Su B, Seshadri M, Luo W, Trump DL, Johnson CS. Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol. Cancer. 119: 563-74. PMID 22833444 DOI: 10.1002/cncr.27531  0.4
2012 Yan L, Ma C, Wang D, Hu Q, Qin M, Conroy JM, Sucheston LE, Ambrosone CB, Johnson CS, Wang J, Liu S. OSAT: a tool for sample-to-batch allocations in genomics experiments. Bmc Genomics. 13: 689. PMID 23228338 DOI: 10.1186/1471-2164-13-689  0.4
2012 Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Rheumatic Diseases Clinics of North America. 38: 161-78. PMID 22525850 DOI: 10.1016/j.rdc.2012.03.014  0.44
2012 Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, Sucheston LE, Tang L, Roberts M, Ciupak G, Davis W, Hwang H, Johnson CS, Trump DL, McCann SE, et al. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Research : Bcr. 14: R58. PMID 22480149 DOI: 10.1186/bcr3162  0.4
2012 Wang D, Yan L, Hu Q, Sucheston LE, Higgins MJ, Ambrosone CB, Johnson CS, Smiraglia DJ, Liu S. IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data. Bioinformatics (Oxford, England). 28: 729-30. PMID 22253290 DOI: 10.1093/bioinformatics/bts013  0.4
2011 Woloszynska-Read A, Johnson CS, Trump DL. Vitamin D and cancer: clinical aspects. Best Practice & Research. Clinical Endocrinology & Metabolism. 25: 605-15. PMID 21872802 DOI: 10.1016/j.beem.2011.06.006  0.44
2011 Hidalgo AA, Deeb KK, Pike JW, Johnson CS, Trump DL. Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription. The Journal of Biological Chemistry. 286: 36228-37. PMID 21868377 DOI: 10.1074/jbc.M111.244061  0.4
2011 Deeb KK, Luo W, Karpf AR, Omilian AR, Bshara W, Tian L, Tangrea MA, Morrison CD, Johnson CS, Trump DL. Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate. Epigenetics : Official Journal of the Dna Methylation Society. 6: 994-1000. PMID 21725204 DOI: 10.4161/epi.6.8.16536  0.4
2011 Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, Davis W, Hong CC, McCann SE, Hwang H, Kulkarni S, Edge SB, O'Connor TL, Ambrosone CB. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. Plos One. 6: e17251. PMID 21386992 DOI: 10.1371/journal.pone.0017251  0.4
2011 Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, Johnson CS, Trump D. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. The Prostate. 71: 368-72. PMID 20812224 DOI: 10.1002/pros.21250  0.4
2011 Jain RK, Trump DL, Egorin MJ, Fernandez M, Johnson CS, Ramanathan RK. A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors. Investigational New Drugs. 29: 1420-5. PMID 20661623 DOI: 10.1007/s10637-010-9492-5  0.44
2011 Rassnick KM, Muindi JR, Johnson CS, Bailey DB, Trump DL. Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs. Cancer Chemotherapy and Pharmacology. 67: 165-71. PMID 20306264 DOI: 10.1007/s00280-010-1304-2  0.44
2011 Trump DL, Johnson CS. The anti-tumor effects of vitamin D in other cancers Vitamin D. 1763-1773. DOI: 10.1016/B978-0-12-381978-9.10090-3  0.4
2011 Trump DL, Johnson CS. Vitamin D and cancer Vitamin D and Cancer. 1-342. DOI: 10.1007/978-1-4419-7188-3  0.4
2010 Ma Y, Trump DL, Johnson CS. Vitamin D in combination cancer treatment. Journal of Cancer. 1: 101-7. PMID 20842231  0.44
2010 Yu WD, Ma Y, Flynn G, Muindi JR, Kong RX, Trump DL, Johnson CS. Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system. Cell Cycle (Georgetown, Tex.). 9: 3022-9. PMID 20699664 DOI: 10.4161/cc.9.15.12381  0.4
2010 Muindi JR, Yu WD, Ma Y, Engler KL, Kong RX, Trump DL, Johnson CS. CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology. 151: 4301-12. PMID 20591973 DOI: 10.1210/en.2009-1156  0.44
2010 Luo W, Karpf AR, Deeb KK, Muindi JR, Morrison CD, Johnson CS, Trump DL. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. Cancer Research. 70: 5953-62. PMID 20587525 DOI: 10.1158/0008-5472.CAN-10-0617  0.44
2010 Ma Y, Yu WD, Trump DL, Johnson CS. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer. 116: 3294-303. PMID 20564622 DOI: 10.1002/cncr.25059  0.44
2010 Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Endocrinology and Metabolism Clinics of North America. 39: 401-18, table of con. PMID 20511060 DOI: 10.1016/j.ecl.2010.02.011  0.44
2010 Hidalgo AA, Trump DL, Johnson CS. Glucocorticoid regulation of the vitamin D receptor. The Journal of Steroid Biochemistry and Molecular Biology. 121: 372-5. PMID 20398752 DOI: 10.1016/j.jsbmb.2010.03.081  0.4
2010 Johnson CS, Chung I, Trump DL. Epigenetic silencing of CYP24 in the tumor microenvironment. The Journal of Steroid Biochemistry and Molecular Biology. 121: 338-42. PMID 20304059 DOI: 10.1016/j.jsbmb.2010.03.046  0.44
2010 Trump DL, Deeb KK, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer Journal (Sudbury, Mass.). 16: 1-9. PMID 20164683 DOI: 10.1097/PPO.0b013e3181c51ee6  0.44
2010 Li F, Cheng Q, Ling X, Stablewski A, Tang L, Foster BA, Johnson CS, Rustum YM, Porter CW. Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: Survivin expression overlaps with stem cell markers American Journal of Pathology. 176: 1629-1638. PMID 20133811 DOI: 10.2353/ajpath.2010.090414  0.4
2009 Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS. Vitamin D deficiency and insufficiency among patients with prostate cancer. Bju International. 104: 909-14. PMID 19426195 DOI: 10.1111/j.1464-410X.2009.08531.x  0.4
2009 Muindi JR, Johnson CS, Trump DL, Christy R, Engler KL, Fakih MG. A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 65: 33-40. PMID 19396601 DOI: 10.1007/s00280-009-1000-2  0.44
2009 Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, Trump DL, Johnson CS. Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Research. 69: 967-75. PMID 19141646 DOI: 10.1158/0008-5472.CAN-08-2307  0.44
2009 Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. International Journal of Colorectal Disease. 24: 219-24. PMID 18830610 DOI: 10.1007/s00384-008-0593-y  0.44
2008 Ma Y, Yu WD, Hershberger PA, Flynn G, Kong RX, Trump DL, Johnson CS. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Molecular Cancer Therapeutics. 7: 3047-55. PMID 18790784 DOI: 10.1158/1535-7163.MCT-08-0243  0.44
2008 Rassnick KM, Muindi JR, Johnson CS, Balkman CE, Ramnath N, Yu WD, Engler KL, Page RL, Trump DL. In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors. Cancer Chemotherapy and Pharmacology. 62: 881-91. PMID 18246349 DOI: 10.1007/s00280-008-0678-x  0.44
2007 Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Reviews. Cancer. 7: 684-700. PMID 17721433 DOI: 10.1038/nrc2196  0.44
2007 Chung I, Yu WD, Karpf AR, Flynn G, Bernardi RJ, Modzelewski RA, Johnson CS, Trump DL. Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. The Journal of Steroid Biochemistry and Molecular Biology. 103: 768-70. PMID 17368191 DOI: 10.1016/j.jsbmb.2006.12.042  0.44
2007 Hidalgo AA, Paredes R, Garcia VM, Flynn G, Johnson CS, Trump DL, Onate SA. Altered VDR-mediated transcriptional activity in prostate cancer stroma. The Journal of Steroid Biochemistry and Molecular Biology. 103: 731-6. PMID 17368189 DOI: 10.1016/j.jsbmb.2006.12.072  0.44
2007 Muindi JR, Nganga A, Engler KL, Coignet LJ, Johnson CS, Trump DL. CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines. The Journal of Steroid Biochemistry and Molecular Biology. 103: 334-7. PMID 17368180 DOI: 10.1016/j.jsbmb.2006.12.060  0.44
2007 Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, Schwartz J, Brattain MG, Hutson A, French R, Johnson CS. A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1216-23. PMID 17317832 DOI: 10.1158/1078-0432.CCR-06-1165  0.44
2007 Alagbala AA, Moser MT, Johnson CS, Trump DL, Foster BA. Characterization of Vitamin D insensitive prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 103: 712-6. PMID 17280828 DOI: 10.1016/j.jsbmb.2006.12.008  0.44
2007 Chung I, Karpf AR, Muindi JR, Conroy JM, Nowak NJ, Johnson CS, Trump DL. Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol. The Journal of Biological Chemistry. 282: 8704-14. PMID 17244627 DOI: 10.1074/jbc.M608894200  0.44
2007 Alagbala AA, Johnson CS, Trump DL, Posner GH, Foster BA. Antitumor effects of two less-calcemic vitamin D analogs (paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells Oncology. 70: 483-492. PMID 17237623 DOI: 10.1159/000098813  0.44
2007 Beer TM, Javle MM, Ryan CW, Garzotto M, Lam GN, Wong A, Henner WD, Johnson CS, Trump DL. Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer. Cancer Chemotherapy and Pharmacology. 59: 581-7. PMID 17066293 DOI: 10.1007/s00280-006-0299-1  0.44
2007 Muindi JR, Peng Y, Wilson JW, Johnson CS, Branch RA, Trump DL. Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients. Cancer Chemotherapy and Pharmacology. 59: 97-104. PMID 16680461 DOI: 10.1007/s00280-006-0247-0  0.44
2006 Flynn G, Chung I, Yu WD, Romano M, Modzelewski RA, Johnson CS, Trump DL. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis. Oncology. 70: 447-57. PMID 17237620 DOI: 10.1159/000098872  0.44
2006 Chung I, Wong MK, Flynn G, Yu WD, Johnson CS, Trump DL. Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells. Cancer Research. 66: 8565-73. PMID 16951169 DOI: 10.1158/0008-5472.CAN-06-0905  0.44
2006 Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells. Cancer Research. 66: 8131-8. PMID 16912191 DOI: 10.1158/0008-5472.CAN-06-1333  0.44
2006 Trump DL, Muindi J, Fakih M, Yu WD, Johnson CS. Vitamin D compounds: clinical development as cancer therapy and prevention agents. Anticancer Research. 26: 2551-6. PMID 16886663  0.44
2006 Johnson CS, Muindi JR, Hershberger PA, Trump DL. The antitumor efficacy of calcitriol: preclinical studies. Anticancer Research. 26: 2543-9. PMID 16886662  0.44
2006 Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS. Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer. Cancer. 106: 2136-42. PMID 16598750 DOI: 10.1002/cncr.21890  0.44
2005 Muindi JR, Potter DM, Peng Y, Johnson CS, Trump DL. Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation. Cancer Chemotherapy and Pharmacology. 56: 492-6. PMID 15918041 DOI: 10.1007/s00280-005-1015-2  0.44
2005 Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, Lee YJ, Xiao H, Herman-Antosiewicz A. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. The Journal of Biological Chemistry. 280: 19911-24. PMID 15764812 DOI: 10.1074/jbc.M412443200  0.44
2004 Trump DL, Hershberger PA, Bernardi RJ, Ahmed S, Muindi J, Fakih M, Yu WD, Johnson CS. Anti-tumor activity of calcitriol: pre-clinical and clinical studies. The Journal of Steroid Biochemistry and Molecular Biology. 89: 519-26. PMID 15225831 DOI: 10.1016/j.jsbmb.2004.03.068  0.44
2004 Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene. 23: 5594-606. PMID 15184882 DOI: 10.1038/sj.onc.1207747  0.44
2004 Lee SO, Lou W, Johnson CS, Trump DL, Gao AC. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. The Prostate. 60: 178-86. PMID 15176047 DOI: 10.1002/pros.20045  0.44
2004 Xiao D, Johnson CS, Trump DL, Singh SV. Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells. Molecular Cancer Therapeutics. 3: 567-75. PMID 15141014  0.44
2004 Muindi JR, Modzelewski RA, Peng Y, Trump DL, Johnson CS. Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses. Oncology. 66: 62-6. PMID 15031600 DOI: 10.1159/000076336  0.44
2003 Muindi JR, Wilson JW, Peng Y, Capozolli MJ, Johnson CS, Trump DL. A limited sampling method for the estimation of serum calcitriol area under the curve in cancer patients. Journal of Clinical Pharmacology. 43: 894-900. PMID 12953346  0.44
2003 Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo. Carcinogenesis. 24: 1665-70. PMID 12896904 DOI: 10.1093/carcin/bgg123  0.44
2003 Xiao D, Srivastava SK, Lew KL, Zeng Y, Hershberger P, Johnson CS, Trump DL, Singh SV. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis. 24: 891-7. PMID 12771033  0.44
2002 Bernardi RJ, Johnson CS, Modzelewski RA, Trump DL. Antiproliferative Effects of 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells. Endocrinology. 143: 2508-2514. PMID 28204431 DOI: 10.1210/endo.143.7.8887  0.44
2002 Muindi JR, Peng Y, Potter DM, Hershberger PA, Tauch JS, Capozzoli MJ, Egorin MJ, Johnson CS, Trump DL. Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clinical Pharmacology and Therapeutics. 72: 648-59. PMID 12496746 DOI: 10.1067/mcp.2002.129305  0.44
2002 Hershberger PA, McGuire TF, Yu WD, Zuhowski EG, Schellens JH, Egorin MJ, Trump DL, Johnson CS. Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Molecular Cancer Therapeutics. 1: 821-9. PMID 12492115  0.44
2002 Johnson CS, Hershberger PA, Trump DL. Vitamin D-related therapies in prostate cancer. Cancer Metastasis Reviews. 21: 147-58. PMID 12465754  0.44
2002 Fakih M, Johnson CS, Trump DL. Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review. Urology. 60: 553-61. PMID 12385906 DOI: 10.1016/S0090-4295(02)01741-7  0.44
2002 Johnson CS, Hershberger PA, Bernardi RJ, Mcguire TF, Trump DL. Vitamin D receptor: a potential target for intervention. Urology. 60: 123-30; discussion 1. PMID 12231068  0.44
2002 Matin K, Egorin MJ, Ballesteros MF, Smith DC, Lembersky B, Day RS, Johnson CS, Trump DL. Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate. Cancer Chemotherapy and Pharmacology. 50: 179-85. PMID 12203099 DOI: 10.1007/s00280-002-0484-9  0.44
2002 Ahmed S, Johnson CS, Rueger RM, Trump DL. Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model. The Journal of Urology. 168: 756-61. PMID 12131364  0.44
2002 Bernardi RJ, Johnson CS, Modzelewski RA, Trump DL. Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells. Endocrinology. 143: 2508-14. PMID 12072382 DOI: 10.1210/endo.143.7.8887  0.44
1997 Johnson CS. The effect of continuous infusion IL-1α on carboplatin-induced thrombocytopenia and anti-tumor activity in RIF-1 tumor bearing mice Oncology Reports. 4: 43-48.  0.4
Show low-probability matches.